Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Historically, sickle cell disease has not been viewed in the chronic pain paradigm because of its recurrent nature. Patients with sickle cell disease may be hospitalized for extended periods of time. As the hospital stay progresses, patients with SCD pain are often observed by clinicians to have improvements in function in areas such as self-care, mobility, and recreation despite continued self-report of high pain scores. This pattern of functional improvement with continued report of high pain intensity scores is common in patients with recurrent and chronic pain. A functional assessment tool that can assess function in the acute inpatient setting is needed.
The purpose of this study is to evaluate the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ), as a measure of daily function in children with sickle cell disease hospitalized with vasoocclusive pain.
| Condition |
|---|
|
Sickle Cell Disease Pain |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Psychometric Evaluation of the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ) in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain |
| Estimated Enrollment: | 200 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Sickle Cell Disease |
Detailed Description:
Refer to Brief Summary
Eligibility| Ages Eligible for Study: | 7 Years to 21 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Children, adolescents, and young adults with sickle cell disease.
Inclusion Criteria:
- Documented sickle cell disease
- Sudden onset of pain consistent with vasoocclusive episode at the time of hospitalization.
- Pain requiring hospitalization and placement on standard clinical guideline for management of acute pain in sickle cell disease during hospitalization
- Cognitive ability to report pain on a 0-10 Numerical Rating Scale (NRS)
- Parental/patient consent and child assent
Exclusion Criteria:
- Primary diagnosis other than vasoocclusive pain
- Concurrent Acute Chest Syndrome (ACS)
- Patient previously enrolled in this study
- Inability to understand English
Contacts and Locations| Contact: William T. Zempsky, M.D. | 860-545-9041 | wzempsk@ccmckids.org |
| Contact: James P Santanelli, M.P.H. | 860-545-9021 | jsantanelli@ccmckids.org |
| United States, Connecticut | |
| Connecticut Children's Medical Center | Recruiting |
| Hartford, Connecticut, United States, 06106 | |
| Contact: William T. Zempsky, M.D. 860-545-9041 wzempsk@ccmckids.org | |
| Contact: John M. Corsi, M.B.A. 860-545-9021 jmcorsi@ccmckids.org | |
| Principal Investigator: William T. Zempsky, M.D. | |
| Principal Investigator: | William T. Zempsky, M.D. | Connecticut Children's Medical Center |
More Information
No publications provided
| Responsible Party: | William Zempsky, MD, Director, Pain Relief Program, Connecticut Children's Medical Center |
| ClinicalTrials.gov Identifier: | NCT01058473 History of Changes |
| Other Study ID Numbers: | CCMC IRB Number 09-115 |
| Study First Received: | January 26, 2010 |
| Last Updated: | February 8, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Connecticut Children's Medical Center:
|
Sickle Cell Disease Pain Assessment |
Additional relevant MeSH terms:
|
Anemia, Sickle Cell Anemia, Hemolytic, Congenital Anemia, Hemolytic Anemia |
Hematologic Diseases Hemoglobinopathies Genetic Diseases, Inborn |
ClinicalTrials.gov processed this record on May 23, 2013